Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer

Clinical Cancer Research

Volumn 16, Issue 14, 2010, Pages 3760-3768

  Wu, Lingling ^a   Chang, Wenjun ^a   Zhao, Jinfeng ^a   Yu, Yongwei ^a   Tan, Xiaojie ^a   Su, Tong ^a   Zhao, Lijun ^a   Huang, Shengdong ^a   Liu, Shiyuan ^b   Cao, Guangwen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Second Affiliated Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOANTIBODY; COMPLEMENTARY DNA; GLYCOPROTEIN; OLFACTOMEDIN 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE MARKER; DNA LIBRARY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTOANTIBODIES; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CLONING, MOLECULAR; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; PEPTIDES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77954736989     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-0193     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Brower V. Biomarker studies abound for early detection of lung cancer. J Natl Cancer Inst 2009;101:11-3.
3. Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007;450:893-8.
4. Patz EF, Jr., Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herndon JE II. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 2007;25:5578-83.
5. Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007; 356:11-20.
6. Tarro G, Perna A, Esposito C. Early diagnosis of lung cancer by detection of tumor liberated protein. J Cell Physiol 2005;203:1-5. (Pubitemid 40328166)
7. de Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005;7:411-23.
8. Wang X, Yu J, Sreekumar A, et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005;353:1224-35.
9. Ran Y, Hu H, Zhou Z, et al. Profiling tumor-associated autoantibodies for the detection of colon cancer. Clin Cancer Res 2008;14: 2696-700.
10. Tong YQ, Zhang ZJ, Liu B, et al. Autoantibodies as potential biomarkers for nasopharyngeal carcinoma. Proteomics 2008;8:3185-93.
11. Lin HS, Talwar HS, Tarca AL, et al. Autoantibody approach for serum-based detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2396-405.
12. Pavoni E, Pucci A, Vaccaro P, et al. A study of the humoral immune response of breast cancer patients to a panel of human tumor antigens identified by phage display. Cancer Detect Prev 2006;30:248-56.
13. Casiano CA, Mediavilla-Varela M, Tan EM. Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics 2006;5:1745-59. (Pubitemid 44688185)
14. Chen G, Wang X, Yu J, et al. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res 2007;67:3461-7.
15. Madoz-Gurpide J, Kuick R, Wang H, Misek DE, Hanash SM. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Mol Cell Proteomics 2008;7:268-81. (Pubitemid 351298441)
16. Qiu J, Hanash S. Autoantibody profiling for cancer detection. Clin Lab Med 2009;29:31-46.
17. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006;1:513-9. (Pubitemid 47181397)
18. Qiu J, Choi G, Li L, et al. Occurrence of autoantibodies to annexin I, 14-3-3 θ and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol 2008;26:5060-6.
19. Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as biomarkers for early cancer detection. FEBS J 2009;276:6880-904.
20. Chang W, Ma L, Lin L, et al. Identification of novel hub genes associated with liver metastasis of gastric cancer. Int J Cancer 2009;125: 2844-53.
21. Fan Y, Murphy TB, Watson RW. digeR: a graphical user interface R package for analyzing 2D-DIGE data. Bioinformatics 2009;25: 3033-4.
22. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008;31:1334-56.
23. Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med 2009;15:303-7.
24. Fernández-Madrid F, VandeVord PJ, Yang X, et al. Antinuclear antibodies as potential markers of lung cancer. Clin Cancer Res 1999;5: 1393-400. (Pubitemid 29282944)
25. Lai CL, Tsai CM, Tsai TT, et al. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients. Clin Cancer Res 1998;4:3025-30.
26. Barembaum M, Moreno TA, LaBonne C, Sechrist J, Bronner-Fraser M. Noelin-1 is a secreted glycoprotein involved in generation of the neural crest. Nat Cell Biol 2000;2:219-25.
27. Wong YF, Cheung TH, Lo KW, et al. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene 2007;26:1971-82.
28. Khan J, Wei JS, Ringner M, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001;7:673-9.
29. Allander SV, Illei PB, Chen Y, et al. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol 2002;161:1587-95. (Pubitemid 35265519)